newsfilter
← Latest News
GlobeNewswire·

Relmada Therapeutics to Participate at the Jefferies Global Healthcare Conference in London

CORAL GABLES, Fla., Nov. 04, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (NASDAQ:RLMD, "Relmada" or the "Company")), a clinical-stage biotechnology company advancing innovative therapies for